688197 首藥控股
按盤價 
40.350 -2.320 (-5.437%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.244 | -17.303 | -23.163 | -16.662 | -28.777 |
| 總資產報酬率 ROA (%) | -1.930 | -15.038 | -20.836 | -15.391 | -25.610 |
| 投入資產回報率 ROIC (%) | -2.201 | -17.062 | -23.029 | -16.570 | -28.483 | 邊際利潤分析 |
| 銷售毛利率 (%) | 100.000 | 96.930 | 98.956 | 97.871 | 99.371 |
| 營業利潤率 (%) | -53.896 | -1,493.787 | -5,376.314 | -3,548.333 | -9,518.597 |
| 息稅前利潤/營業總收入 (%) | -53.849 | -1,492.472 | -5,511.391 | -3,911.122 | -10,613.206 |
| 淨利潤/營業總收入 (%) | -53.896 | -1,486.393 | -5,376.400 | -3,548.792 | -9,512.739 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 117.414 | 160.983 | 106.795 | 107.506 | 114.578 |
| 價值變動淨收益/利潤總額(%) | -18.455 | -12.763 | -8.186 | -3.827 | -0.655 |
| 營業外收支淨額/利潤總額(%) | 0.000 | -0.497 | 0.002 | 0.013 | -0.062 | 償債能力分析 |
| 流動比率 (X) | 6.892 | 6.901 | 7.054 | 10.898 | 13.495 |
| 速動比率 (X) | 6.864 | 6.871 | 7.024 | 10.895 | 13.469 |
| 資產負債率 (%) | 13.912 | 14.036 | 12.276 | 8.197 | 7.137 |
| 帶息債務/全部投入資本 (%) | 0.699 | 0.680 | 0.573 | 0.221 | 0.485 |
| 股東權益/帶息債務 (%) | 14,033.799 | 14,421.430 | 17,304.741 | 45,149.973 | 20,485.261 |
| 股東權益/負債合計 (%) | 618.813 | 612.471 | 714.581 | 1,119.970 | 1,301.084 |
| 利息保障倍數 (X) | -1,159.845 | 245.534 | 40.828 | 10.794 | 9.644 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 8.167 | 8.780 | 8.321 | 0.000 | 374.343 |
| 存貨周轉天數 (天) | -- | 4,391.232 | 16,031.738 | 4,113.774 | 58,806.566 |
| 備註： | 即時報價更新時間為 22/05/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
